Renowned Speakers
Bruce Leonard
University of Texas Medical Branch, Galveston UK
Juli Daniels
Miami Dade College BenjamÃn León School of Nursing USA
Hilario Noveno
St. Paul University Manila Graduate School Philippines
Sibel Catirli Enar
Assistant Cardilogist,Turkiye Hospital Turkey
Miguel Angel Maluf
São Paulo Federal University Brazil
Ketevan Chagunava
Tbilisi State University Georgia
Riccardo Turri
Mirano General Hospital Italy
Christy Cotner
California Baptist University UAE
Recommended Global Healthcare Management Webinars & Conferences
Asia Pacific & Middle East
Euro Heart Failure 2027
Welcome Message
It is our great pleasure to welcome you to the 38th European Heart and Heart Failure Congress, taking place on May 17–18, 2027, in Paris, France.
This distinguished congress will bring together cardiologists, heart failure specialists, researchers, clinicians, surgeons, and healthcare professionals from across the globe to discuss the latest advancements in cardiovascular medicine. Centered around the theme “Bridging Generations, Uniting Disciplines, Advancing Heart Failure Care,” the conference aims to foster collaboration between emerging and experienced professionals while integrating multidisciplinary approaches to improve patient outcomes in heart failure management.
Through keynote lectures, scientific sessions, and engaging panel discussions, participants will explore a wide spectrum of topics including heart failure diagnosis and management, advanced therapeutics, interventional cardiology, cardiac imaging, preventive cardiology, and innovations in cardiovascular research. The congress will emphasize the importance of collaborative care, technological advancements, and evidence-based practices in addressing the growing global burden of heart failure.
Set in the vibrant and historic city of Paris, this congress offers not only a rich academic platform but also an excellent opportunity to network with leading experts, exchange knowledge, and build meaningful professional connections.
We are honored to welcome you and look forward to your active participation in making the 38th European Heart and Heart Failure Congress a truly successful and impactful event.
About Conference
On behalf of the 38th European Heart & Heart Failure Congress Committee we invite all the eminent speakers around the world to attend the EURO HEART FAILURE 2026 conference scheduled on July 17-18, 2027 at Paris, France
EURO HEART FAILURE 2027 The incorporation of new technologies and research findings will be a special focus of the Congress. It will also bring together expert clinicians, researchers and leaders of cardiac health stakeholder organisations, offering an outstanding set of plenary and state-of - the-art lectures, educational courses, Online symposia with experts and sessions designed by cardiology professionals and cardiac specialists and for early careers.
The main aim of is to provide an excellent platform for the exchange of ideas and authoritative opinions by leading scientists covering the entire spectrum of cardiovascular disease and heart failure research and sharing the cross-cultural experiences of different treatment procedures.
EURO HEART FAILURE 2027 is an international conference of cardiologists and heart failure committee to discuss the future of cardiac health and cardiovascular disorders in terms of collaboration, structures and organizational development and advances in cardio-metabolic health and Interventional Cardiology.
Theme: "Bridging Generations, Uniting Disciplines, Advancing Heart Failure Care"
Why to attend???
With members from around the world concentrated on learning about cardiothoracic and its advances; this is your best opportunity to reach the biggest summit of participants from the cardiology & coronary disease community. Lead presentations, distribute information, meet with current and potential scientists, mark a splash with new drug developments, and receive name recognition at this 2-day conference. Well known renowned speakers, the most recent techniques, developments, and the newest updates in Cardiothoracic are signs of this Event.
The participants can find exclusive sessions and panel discussions on latest revolutions in Cardiac Surgeries and Heart Failure by:
- Lectures from renowned speakers
- Keynote forums by Prominent Professors
- Open Invention Challenges
- Live video presentations by Young Researchers
- Unique techniques to improve your research
- Perfect platform for World-wide business and Networking opportunities
- Come across with the editors of referred journals, Society and Association members across the world
Target Audience:
- Cardiology Scientists
- Cardiac Physicians
- Cardiac Nurses
- Heart Disease Researchers
- Cardiology Fellows
- Neuro-Cardiology Experts
- Medical Colleges
- Cardiology Associations and Societies
- Manufacturing Medical Devices Companies
- Business Entrepreneurs
- Training Institutes
Sessions
Track 1: Heart Diseases: Unlike cardiovascular diseases, which characterize problems with the blood vessels and circulatory system as well as the heart, heart disease specify to issues & deformities in the heart itself.
There are many types of heart diseases & major types are listed here
- Congenital heart disease
- Arrhythmia
- Coronary artery disease
- Dilated cardiomyopathy
- Myocardial infarction
- Heart failure
- Mitral regurgitation
- Mitral Valve Prolapse
Heart diseases are caused due to different reasons & the major symptoms of Heart diseases are:
- Fluttering in the Chest
- Rapid heartbeats (Tachycardia)
- Slow heart beats (Bradycardia)
- Chest Pain
- Shortness of breath
- Dizziness
- Discomfort
Cardiology Associations:
Track 2: Heart Failure: Heart failure is caused due to failure of heart to pump an in-adequate supply of oxygen rich blood which causes disruption in functioning of body. Heart failure is a condition of collection of symptoms which weakens your heart
Symptoms of Heart Failure:
- Excessive Fatigue
- Abdominal Swelling
- shortness of breath
- heart palpitations
- a loss of appetite
- sudden weight gain
Cardiology Associations:
Track 3: Arrhythmias: An arrhythmia is caused by an interruption of your heart’s normal electrical system, which regulates your heart rate and heart rhythm. Usually arrhythmias are completely benign and inconsequential, while few are extremely dangerous and life-threatening. And some of them, while not particularly dangerous, produce symptoms that can be quite disruptive to your life. One of the major causes which causes arrhythmias would include Diabetes, Mental Stress & Smoking
Cardiology Associations:
Track 4: Hypertension: Hypertension is determined by the amount of blood your heart pumps and the amount of resistance to blood flow in your arteries. High blood pressure or hypertension increases the risk of heart disease and Cardiac arrest. You can have high hypertension for years without any symptoms & without symptoms, it can cause damage to blood vessels and your heart continues and can be detected. Treatment for hypertension is necessary which includes both prescription medication and healthy lifestyle changes. If the conditions aren’t treated, it could lead to health issues, including heart attack and stroke
Cardiology Associations:
Track 5: Molecular Cardiology: Molecular Cardiology is basically the study of genetic heart disorders. It applies molecular biology techniques to study the mechanism of human cardiovascular diseases. It also uses clinical cases to discover novel pathways that regulate metabolic diseases, aging, Cardiac hypertrophy
Cardiology Associations:
Track 6: Pediatric Cardiology: Pediatric cardiologists are the ones who diagnose, treat, and manage heart problems in children, including Congenital heart diseases where the children are born with holes between chambers of the heat or valve problems or abnormal blood vessels
Cardiology Associations:
Track 7: Cardio metabolic Health: Cardio metabolic health is a relatively new discover of term that encompasses cardiovascular and metabolic diseases which includes type 2 diabetes and metabolic syndrome. Resulting in such conditions is the leading cause of preventable death worldwide. The symptoms share a common risk factor like overweight, hypertension etc. which can be controlled by diet plan change & change in lifestyle
Cardiology Associations:
Track 8: Diabetes: People who are having diabetes are more likely to develop heart disease and have a greater risk of a heart attack or a stroke. They develop certain conditions, or risk factors, that increase the chances of having heart disease or stroke, such as high blood pressure or high cholesterol.
If you have diagnosed with diabetes, you need to protect your heart and health by managing your blood glucose levels, which is also called as blood sugar, as well as your blood pressure and cholesterol
Cardiology Associations:
Track 9: Interventional Cardiology: An interventional cardiologist recommends the patients to undergo an angiogram in order to gather precise information about blockage in the arteries. An interventional cardiologist will undergo one to two years of additional education and training in diagnosing & treating the heart diseases conditions. Additional to that they also diagnose and treat structural heart condition through catheter based procedures such as stenting & angioplasty
Cardiology Associations:
Track 10: Cardiovascular Medicine: The Medicine which is used to treat various related cardiovascular diseases. Treatment of heart and cardiovascular ailments frequently requires the organization of various prescriptions for extensive stretches of time to patients prone to be old and experiencing a scope of comorbid conditions level headed endorsing is recommended by clinical pharmacology is basic if the correct medication is to be regulated to the correct patient, at the ideal time, and at the correct cost.
This requires a valuation for the key standards of clinical pharmacology, and explicit information of individual treatments. Cardiovascular Toxicology collectively deals with the adverse effects on the heart or blood systems which result from exposure to toxic chemicals. It can be also caused due to any drug-drug interaction or drug induced action. It may result in severe heart diseases conditions
Cardiology Associations:
Track 11: Nuclear Cardiology: Nuclear cardiology deals with the study & use of non-invasive techniques to assess myocardial blood flow to evaluate the pumping function of the heart as well as visualize the size and location of a heart attack. The major techniques of nuclear cardiology are myocardial perfusion imaging which is the most widely used
Cardiology Associations:
Track 12: Myocardial Perfusion Imaging: Myocardial perfusion images are combined by performing exercise to assess the blood flow to the heart muscle.
Cardiology Associations:
Track 13: Cardio-oncology: Cardio-oncology is the crossway of heart conditions in patients who have been treated for cancer. Cardiologists can determine patients for potential risk of developing heart conditions if patients take certain types of cancer drugs, or following any radiation treatment to the chest
Cardiology Associations:
Track 14: Neuro-cardiology: Neuro-cardiology is the study of neurological, neuroanatomical, and the neurophysiological aspects of cardiology. It also includes the neurological origins of cardiac disorders. The effects of stress on the heart are studied in terms with both the peripheral nervous system and the central nervous system
Cardiology Associations:
Track 15: Heart diseases in Women: Heart diseases in Women are the leading killer of women all around the world. However identifying the symptoms & treating them can save many lives. The major symptoms of Heart diseases in women are:
- Pain in either one or both arms
- Dizziness and Unusual fatigue
- Pain in Neck, shoulder, upper back, jaw or abdominal discomfort
- Sweating, Nausea or vomiting
- Shortness of breath
Cardiology Associations:
Track 16: Geriatric Cardiology: Geriatric cardiology is the branch of medicine and cardiology that deals with the cardiovascular disorders in elderly persons. Heart disorders such as arrhythmias (as atrial fibrillation), coronary heart disease including myocardial infarction, heart failure, cardiomyopathy, and others are common and are a major cause of mortality in elderly people. Collectively Vascular disorders such as atherosclerosis and peripheral arterial disease cause significant morbidity and mortality in aged people
Cardiology Associations:
Track 17: Artificial Intelligence in Cardiology: Artificial intelligence (AI) is a rapidly evolving field in medicine, especially in cardiology. Artificial intelligence is defined as the ‘theory and Implementations of computer systems able to perform tasks normally requiring human intelligence’. By creating algorithms using a variety of neural networks, we enable dynamic deep machine learning. Deep machine learning mimics the human brain by using large high-quality data sets to create layers of neural networks to generate automated predictions, interpret image data and develop pattern recognition. AI aims to aid cardiologists in making better decisions, improve workflow, productivity, and cost-effectiveness and ultimately patient outcomes.
Cardiology Associations:
Track 18: Cardiac Nursing: Cardiac Nursing is a Speciality to fame that works with patients who experience the side effects in various states of the cardiovascular system. Cardiac nurses treat conditions like unstable angina, myocardial infractions, Coronary artery disease, cardiomyopathy, Cardiac dysrhythmia and congestive cardiovascular breakdown under the supervision of a cardiologist. Cardiac nurses perform postoperative consideration on stress-test evaluations, surgical units, cardiac monitoring, health evaluations, and vascular monitoring. Cardiac nurses should have more advanced in Cardiac Life Support and Basic Life Support certification. Cardiac nurses must have specific aptitudes including defibrillation, electrocardiogram checking and drug organization by constant intravenous dribble. Cardiac nurses care for individuals with cardiovascular ailment and collaborate with their patient's families. They may screen and treat intensely ill patients, or they may
Concentrate on cardiovascular recovery helping patients make lifestyle changes to prevent the worsening of their disease
Cardiology Associations:
Track 19: Cardiac diagnostic tests: New tests are always being implemented to assist the comprehension of the disease, injury, and congenital (present during childbirth) or acquired abnormalities of the heart. The diagnostic procedures in cardiology are the techniques for identifying heart conditions associated with healthy vs. unhealthy, pathologic cardiac function.
Cardiology Associations:
Track 20: Cardiac Surgery: Cardiovascular surgery is also known as cardio thoracic surgery- which is operated on heart by the cardiac surgeons involved in surgical treatment of organs inside the thorax.
There are major types of cardiac surgeries performed are
- Open heart surgery
- Modern beating heart surgery
- Minimally invasive surgery
- Coronary artery bypass grafting
- Heart transplant
Cardiology Associations:
Track 21: Clinical cases in cardiology: Our all Cardiology conferences 2020 have Case Studies that act as informative guides to the people who may also face comparable issues. Usually, Case Studies in Cardiovascular Medicine 2020, should detail a specific therapeutic case, reporting the medical history of the patient. They should discuss examinations attempted in order to decide a diagnosis or differentiate between possible diagnoses and should indicate the sort of treatment the patient experienced accordingly. In one piece we can conclude that Case Studies is a valuable and instructive piece of every physician’s or doctor's medicinal studies, which really urge us to include this session track on our international heart failure congress 2020 which will be held at Paris, France.
Cardiology Associations:
Conference Agenda
DAY 1 AGENDA
|
Time |
Session |
Details |
|
08:30 – 09:30 AM |
Registration & Welcome Coffee |
Participant registration and networking |
|
09:30 – 10:00 AM |
Inaugural Ceremony & Welcome Address |
Opening remarks by Organizing Committee |
|
10:00 – 10:30 AM |
Opening Keynote Speech |
Keynote lecture by an eminent expert in skincare and cosmetology |
|
10:30 – 11:00 AM |
Networking Break |
Refreshments and interaction |
|
11:00 AM – 01:00 PM |
Scientific Session I: Advances in Heart Failure Diagnosis and Precision Cardiology |
Innovations in heart failure diagnosis, precision medicine, biomarkers, cardiovascular imaging, genetics, and individualized patient management |
|
01:00 – 02:00 PM |
Lunch Break |
Buffet lunch and networking |
|
02:00 – 04:00 PM |
Scientific Session II: Contemporary Heart Failure Therapies and Clinical Management |
Latest advances in pharmacological therapies, device-based treatments, interventional cardiology, cardiac resynchronization therapy, ventricular assist devices, and multidisciplinary care |
|
04:00 – 04:30 PM |
Coffee Break |
Informal discussions and refreshments |
|
04:30 – 06:00 PM |
Panel Discussion |
The Future of AI, Digital Health, Remote Monitoring, and Personalized Heart Failure Care |
|
06:00 – 06:15 PM |
Closing Remarks |
Summary of Day 1 sessions |
|
07:00 PM onwards |
Welcome Dinner & Networking Reception |
Evening social gathering for delegates |
DAY 2 AGENDA
|
Time |
Session |
Details |
|
09:00 – 09:30 AM |
Morning Coffee & Networking |
Start the day with informal discussions and collaboration opportunities |
|
09:30 – 11:00 AM |
Scientific Session III: Preventive Cardiology, Cardiac Rehabilitation, and Chronic Heart Failure Care |
Evidence-based prevention strategies, rehabilitation programs, lifestyle interventions, chronic disease management, and patient-centered care |
|
11:00 – 11:30 AM |
Coffee Break |
Refreshments and networking |
|
11:30 AM – 01:00 PM |
Scientific Session IV: Cardiovascular Research, Emerging Technologies, and Translational Medicine |
Novel therapeutics, regenerative medicine, stem cell research, cardiovascular devices, digital innovations, and translational research in heart failure |
|
01:00 – 02:00 PM |
Lunch Break |
Buffet lunch and networking |
|
02:00 – 03:30 PM |
Scientific Session V: Heart Failure Across the Lifespan and Multidisciplinary Care |
Pediatric and adult heart failure, cardio-oncology, women's cardiovascular health, geriatric cardiology, multidisciplinary collaboration, and global healthcare strategies |
|
03:30 – 04:00 PM |
Networking Break |
Interaction and collaboration among participants |
|
04:00 – 05:30 PM |
Poster Presentations & Young Researcher Forum |
Presentations from emerging researchers and poster contributors |
|
05:30 – 06:00 PM |
Awards & Certificate Distribution |
Recognition of best presentations and closing ceremony |
|
06:00 – 06:15 PM |
Vote of Thanks & Closing Remarks |
Appreciation note and conclusion of the conference |
Market Analysis
Heart failure affects people of all ages, from children and young adults to the middle-aged and the senior citizens. Almost 1.4 million persons with CHD are under 60 years of age. CHD is present in 2 percent of persons age 40 to 59. More than 5 percent of persons age 60 to 69 have CHD.
According to the latest WHO data published in 2017 Coronary Heart Disease Demises in France reached 33,637 or 35.02% of total deaths. Survival rates in patients with heart failure were 75.9% (95% confidence interval 75.5% to 76.3%) at one year, 45.5% (45.1 to 46.0) at five years, 24.5% (23.9 to 25.0) at 10 years, and 12.7% (11.9 to 13.5) at 15 years.
Since 2006 to 2016, the yearly mortality rate creditable to coronary heart disease declined 31.8% and the actual number of deaths declined 14.6%, but the problem and risk factors remain terrifyingly high. The estimated direct and indirect cost of heart disease in 2015 to 2016 (average annual) was $218.7 billion.
Growth of Cardiology Market:-
Overall, one, five, and 10 year survival rates increased by 6.6% (from 74.2% in 2000 to 80.8% in 2016), 7.2% (from 41.0% in 2000 to 48.2% in 2012), and 6.4% (from 19.8% in 2000 to 26.2% in 2007), respectively. There were 30 906 demises in the heart failure group over the study period. Heart failure was listed on the death record in 13 093 (42.4%) of these patients, and in 2237 (7.2%) it was the primary cause of death. Improvement in survival was greater for patients not requiring admission to hospital around the time of diagnosis (median difference 2.4 years; 5.3 v 2.9 years, P<0.001). There was a deprivation gap in median survival of 0.5 years between people who were least deprived and those who were most deprived (4.6 v 4.1 years, P<0.001).
The goal of this is to evaluate cardiovascular risk among the France population quantify the impact of main risk factors on cardiovascular mortality and to identify potential modifiable factors for improving the cardiovascular health.
Treatment:
The FDA approved the combination tablet sacubitril/valsartan (Entresto) in 2015 to reduce the risk of cardiovascular death and hospitalization for heart failure in patients with NYHA class II-IV heart failure and reduced ejection fraction.
- Coronary bypass surgery
- Heart valve repair or replacement
- Implantable cardioverter-defibrillators (ICDs)
- Cardiac resynchronization therapy (CRT)
- Ventricular assist devices (VADs)
- Heart transplant.
So cardiology conferences are going to be a good success today because the awareness for the treatment of vas diseases is enormously essential among the individuals and everyone can come back to grasp about the new researches happening and innovations within the field of medicine.
Participants and Participation options
- Speaker: Deliver keynote or invited lectures, share research and innovations with global delegates.
- Delegate: Attend sessions, panel discussions, networking events; access conference materials and expert interactions.
- Poster Presenter: Showcase original research via printed or digital posters; engage in one-on-one discussions.
- Exhibitor: Display products, technologies, or services; network with delegates and potential collaborators.
- Video Presentation: Present research via recorded sessions; ideal for those unable to attend in person.
- E-Poster Presenter: Share research electronically; participate in virtual Q&A and discussions.
- Virtual Registration: Attend live-streamed sessions, access recordings, materials, and virtual networking; ideal for international participants.
Participant Benefits
- Earn CPD/CME points
- Networking with global experts and peers
- Certificate of participation
- DOI publication opportunities in conference proceedings
- Access to cutting-edge research
- Professional visibility for speakers, presenters, and exhibitors
- Opportunities for global collaboration
Abstract Submission & Registration Timeline
- Abstract Submission: Now Open
- Early Bird Registration: March 28th, 2027
- Standard Registration: April 30th, 2027
- Final Registration Deadline: May 15th, 2027
Abstract Details: Peer-reviewed; accepted abstracts published in proceedings with DOI for global visibility. Authors receive an Abstract Acceptance Letter confirming inclusion.
Secure Your Place & Submit Your Abstract
- Registration Link: https://heartdiseases.conferenceseries.com/registration.php
- Abstract submission: https://heartdiseases.conferenceseries.com/abstract-submission.php
Don’t miss the opportunity to participate, present your research, and network with global experts.
For Inquiries:
- Email: heartdiseases@speakersconclave.com
- Phone: +44 2045861247
- Website: https://heartdiseases.conferenceseries.com/
To Collaborate Scientific Professionals around the World
Conference Date May 17-18, 2027
For Sponsors & Exhibitors
Speaker Opportunity
Useful Links
Past Conference Report
Supported By
All accepted abstracts will be published in respective Conference Series International Journals.
Abstracts will be provided with Digital Object Identifier by
